We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+25.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$180B
AUM Growth
+$31.5B
(+21%)
Cap. Flow
+$10.5B
Cap. Flow
% of AUM
5.84%
Top 10 Holdings %
Top 10 Hldgs %
33.8%
Holding
1,702
New
84
Increased
860
Reduced
221
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$756M |
| 2 |
NVIDIA
NVDA
|
+$597M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$587M |
| 4 |
Amazon
AMZN
|
+$496M |
| 5 |
Microsoft
MSFT
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$309M |
| 2 |
Zoetis
ZTS
|
+$299M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$144M |
| 5 |
Broadridge
BR
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.05% |
| 2 | Financials | 12.49% |
| 3 | Communication Services | 10.03% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Healthcare | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
CleanSpark
CLSK
$3.16B
| $247K | ﹤0.01% |
16,967
-4,314
| -20% | -$60.9K |
|
1002
Sarepta Therapeutics
SRPT
$1.77B
| $245K | ﹤0.01% |
13,607
-5
| -0% | -$95 |
|
1003
Azenta
AZTA
$1.48B
| $240K | ﹤0.01% |
9,387
+3,471
| +59% | +$77.8K |
|
1004
BioNTech
BNTX
$23.5B
| $237K | ﹤0.01% |
2,551
+261
| +11% | +$24.6K |
|
1005
Novavax
NVAX
$1.31B
| $237K | ﹤0.01% |
25,162
-10,575
| -30% | -$94.8K |
|
|
GPGI
1006
GPGI Inc
GPGI
$4.35B
| $233K | ﹤0.01% |
14,721
+4,485
| +44% | +$64.2K |
|
1007
Lexeo Therapeutics
LXEO
$378M
| $233K | ﹤0.01% |
49,988
+24,411
| +95% | +$132K |
|
|
FRVO
1008
Fervo Energy
FRVO
$7.62B
| $231K | ﹤0.01% |
+7,900
| New | +$285K |
|
|
FRMI
1009
Fermi Inc
FRMI
$3.94B
| $230K | ﹤0.01% |
25,100
| – | – |
|
1010
Stellantis
STLA
$20.8B
| $229K | ﹤0.01% |
39,958
+11,142
| +39% | +$82.4K |
|
1011
Kyverna Therapeutics
KYTX
$484M
| $229K | ﹤0.01% |
+25,741
| New | +$229K |
|
|
BAND
1012
Bandwidth Inc
BAND
$1.61B
| $213K | ﹤0.01% |
3,366
-4,108
| -55% | -$184K |
|
1013
Wave Life Sciences
WVE
$1.2B
| $212K | ﹤0.01% |
36,473
+3,450
| +10% | +$22.9K |
|
|
CHYM
1014
Chime Financial
CHYM
$11B
| $211K | ﹤0.01% |
10,315
+2,485
| +32% | +$48.2K |
|
1015
Recursion Pharmaceuticals
RXRX
$1.73B
| $211K | ﹤0.01% |
57,437
+16,389
| +40% | +$54.6K |
|
1016
Ionis Pharmaceuticals
IONS
$9.4B
| $208K | ﹤0.01% |
2,618
-75
| -3% | -$5.64K |
|
1017
Roivant Sciences
ROIV
$26.2B
| $205K | ﹤0.01% |
5,803
-2,519
| -30% | -$74.4K |
|
1018
NCR Voyix
VYX
$1.14B
| $198K | ﹤0.01% |
+24,296
| New | +$171K |
|
1019
Agilysys
AGYS
$3.06B
| $194K | ﹤0.01% |
1,861
+208
| +13% | +$16.1K |
|
1020
BILL Holdings
BILL
$4.78B
| $194K | ﹤0.01% |
5,376
+1,503
| +39% | +$55.4K |
|
1021
Inhibrx
INBX
$1.3B
| $194K | ﹤0.01% |
2,045
-981
| -32% | -$98.3K |
|
1022
HealthEquity
HQY
$8.75B
| $193K | ﹤0.01% |
2,139
-277
| -11% | -$23.5K |
|
1023
Neurogene
NGNE
$712M
| $192K | ﹤0.01% |
6,090
-1,904
| -24% | -$52.4K |
|
1024
Pacira BioSciences
PCRX
$997M
| $191K | ﹤0.01% |
7,509
+7,337
| +4,266% | +$173K |
|
|
NXDT
1025
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $187K | ﹤0.01% |
36,088
+828
| +2% | +$4.08K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Mitsubishi UFJ Asset Management held 1,702 positions worth $180B, up 21% from $149B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Mitsubishi UFJ Asset Management deployed $10.5B of net new capital in Q2 2026, opening 84 new positions and adding to 860 existing holdings. Its largest new stake was Honeywell Aerospace: 929,990 shares worth $206M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Texas Instruments, an estimated $309M trimmed.
- Mitsubishi UFJ Asset Management's largest Q2 2026 buy was Honeywell Aerospace: 929,990 shares worth $206M.
- Mitsubishi UFJ Asset Management added most to Apple in Q2 2026, an estimated $756M increase.
- Mitsubishi UFJ Asset Management's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $309M.
- Mitsubishi UFJ Asset Management fully exited Coterra Energy in Q2 2026, selling an estimated $61.3M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 34% of its $180B portfolio in Q2 2026.
- Mitsubishi UFJ Asset Management opened 84 new positions and closed 44 in Q2 2026.
- Mitsubishi UFJ Asset Management's portfolio value rose 21% quarter-over-quarter to $180B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.